Volume 5, Issue 1 (Spring & Summer 2021)
J Res Urol 2021, 5(1): 16-21 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohammad Rahimi M, Hemmati Ghavshough M, Zomorrodi A, Shabanifard M. Survival Rate of Recipients of Cadaveric-Donor Kidneys in the Transplant unit of Imam Reza Hospital, Tabriz, during the Last Five Years. J Res Urol 2021; 5 (1) :16-21
URL: http://urology.umsha.ac.ir/article-1-89-en.html
URL: http://urology.umsha.ac.ir/article-1-89-en.html
1- Department of Urology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran , Mm.rahimi1357@gmail.com
2- School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3- Department of Urology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2- School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3- Department of Urology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract: (3581 Views)
Background and Objective: Determining the efficiency of kidney transplantation, the survival rate of patients after surgery, and the role of factors affecting this survival is of particular importance. The present study aimed to assess the survival rate of recipients of cadaveric-donor kidneys in the transplant unit of Imam Reza (AS) Hospital in Tabriz during the last five years.
Materials and Methods: This descriptive-analytical study was conducted on the recipients of cadaveric-donor kidneys. The data were collected from documents of donor patients, evaluation of blood and urine tests, and follow-up. The required examinations included height, weight, body mass index, age of recipient and donor, blood group, and RH of donor and recipient, donor-recipient kinship, duration of dialysis, year of transplantation, duration of transplantation, duration of patient survival, other drugs (aspirin, heart, hypertension, and cholesterol-lowering medications).
Results: In the present study, the survival rates of kidney transplantation at 1, 2, 3, and 5 years were 97%, 90.9%, 79.1%, and 67%, respectively. Moreover, 1, 2, 3, and 5-year survival rates of patients were reported as 98%, 95.5%, 90.9% and 87.4%, respectively. Furthermore, gender and age of kidney donor and recipient were not significantly correlated with renal transplant survival.
Conclusion: Kidney transplantation is the most appropriate treatment option for end-stage renal disease patients, leading to better survival and improved quality of life.
Materials and Methods: This descriptive-analytical study was conducted on the recipients of cadaveric-donor kidneys. The data were collected from documents of donor patients, evaluation of blood and urine tests, and follow-up. The required examinations included height, weight, body mass index, age of recipient and donor, blood group, and RH of donor and recipient, donor-recipient kinship, duration of dialysis, year of transplantation, duration of transplantation, duration of patient survival, other drugs (aspirin, heart, hypertension, and cholesterol-lowering medications).
Results: In the present study, the survival rates of kidney transplantation at 1, 2, 3, and 5 years were 97%, 90.9%, 79.1%, and 67%, respectively. Moreover, 1, 2, 3, and 5-year survival rates of patients were reported as 98%, 95.5%, 90.9% and 87.4%, respectively. Furthermore, gender and age of kidney donor and recipient were not significantly correlated with renal transplant survival.
Conclusion: Kidney transplantation is the most appropriate treatment option for end-stage renal disease patients, leading to better survival and improved quality of life.
Type of Study: Research |
Subject:
Endourology
Received: 2021/10/11 | Accepted: 2021/11/28 | Published: 2021/09/1
Received: 2021/10/11 | Accepted: 2021/11/28 | Published: 2021/09/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences.
Published by UMSHA Press
Journal Tel: +9881 38380283
Publisher Tel: +988138380548
Website: http://urology.umsha.ac.ir
Email: urology [at]umsha.ac.ir
